EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk

Peter Rossing iD, Tine Willum Hansen, Thomas Kümler

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15747 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Peter Rossing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) currently affects approximately 850 million people globally and is continuing to increase in prevalence as well as in importance as a cause of death. The excess mortality related to CKD is mostly caused by an increase in cardiovascular disease. This includes atherosclerotic cardiovascular disease as many promoters of atherosclerosis, such as blood pressure, lipid levels and hypercoagulation, are increased in people with CKD. Diabetes is a leading cause of CKD contributing to the risk of CVD, and obesity is also increasingly prevalent. Management of these risk factors is therefore very important in CKD, and to reduce risk of CKD progression. Heart failure is also more prevalent in CKD and, again, many risk factors are shared. The concept of foundational pillars in the management of heart failure has been adapted to the treatment of CKD, with many organ‐protective interventions, such renin‐angiotensin system blockade, sodium‐glucose cotransporter‐2 inhibition and mineralocorticoid receptor antagonism, reducing the risk for mortality in heart failure with reduced ejection fraction, but also for progression of CKD. Atrial fibrillation is also more common with CKD and affects the management of the former. In this review these non‐renal complications of CKD are discussed, along with how the risk of these complications should be managed. Many new opportunities have demonstrated heart and kidney organ protection, but implementation is a challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCardiovascular DiseasesHumansRisk FactorsHeart FailureAtrial FibrillationDisease ProgressionObesity

Stichwörter der Autor:innen

GLP‐1SGLT2 inhibitorcardiovascular diseasediabetic nephropathyheart failure

Autor:innen und Institutionen

  • Clinical Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Peter Rossing

Zitieren

APA

Rossing, P., Hansen, T. W., & Kümler, T. (2024). Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15747

Vancouver

Rossing P, Hansen TW, Kümler T. Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15747

BibTeX
@article{Rossing2024,
  author = {Rossing, Peter and Hansen, Tine Willum and Kümler, Thomas},
  title = {Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15747}
}
Kostenlos starten →